Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,894 public trials 2,121 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

Ipilimumab for Head and Neck Cancer Patients

NCT02812524

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Portland Providence Medical Center Portland, Oregon, United States

View Trial Details

Active, not recruiting

Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure

NCT06045975

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Hospitl Avicenne Bobigny, France

View Trial Details

Active, not recruiting

Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)

NCT06143748

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Active, not recruiting

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

NCT03682289

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +43 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

University of California, San Francisco San Francisco, California, United States

University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Active, not recruiting

Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas

NCT04701307

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma

NCT03389477

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Active, not recruiting

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

NCT01590069

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +34 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

NCT04393350

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Active, not recruiting

Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer

NCT04605731

Conditions: Adenocarcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, +18 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma

NCT05294120

Conditions: Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +4 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions